Search clinical trials for: Poly (ADP-ribose) polymerase (PARP) Inhibitor Therapy
Total 121597 results
-
Tesaro, Inc.WithdrawnLymphoma | Mantle-Cell
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompletedMelanoma NeoplasmsUnited States, United Kingdom
-
Teva Branded Pharmaceutical Products R&D, Inc.Terminated
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompleted
-
AstraZenecaCompletedAdvanced Ovarian Cancer | Paclitaxel | Carboplatin | Triple Negative Metastatic Breast CancerBelgium, Netherlands, United Kingdom
-
Abramson Cancer Center at Penn MedicineActive, not recruitingProstate CancerUnited States
-
Merck Sharp & Dohme LLCTerminatedNeoplasms | Solid Tumors
-
The University of Hong KongRecruitingRecurrent Glioblastoma | Recurrent Glioma | Poly ADP Ribose Polymerase (PARP) Inhibitor | PTEN Gene Inactivation | IDH MutationHong Kong
-
University of Alabama at BirminghamWithdrawnOvarian Cancer RecurrentUnited States
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompletedMalignant Solid TumorsUnited Kingdom
-
National Cancer Institute (NCI)RecruitingEGFR-Mutated Non-Small-Cell Lung Carcinoma | Small Cell/NeuroendocrineUnited States
-
AstraZenecaCompletedNeoplasm MetastasisUnited Kingdom
-
University of Alabama at BirminghamTerminatedOvarian Cancer | Resistant BRCA Wild-Type Ovarian CancerUnited States
-
ARCAGY/ GINECO GROUPTesaro, Inc.Completed
-
Tianjin Medical University Cancer Institute and...Recruiting
-
Inotek Pharmaceuticals CorporationCompletedAcute Myocardial InfarctionUnited States, Israel
-
University of Alabama at BirminghamTesaro, Inc.; Susan G. Komen Breast Cancer Foundation; Translational Breast Cancer... and other collaboratorsRecruitingMetastatic Breast Cancer | HER2 Positive Breast CarcinomaUnited States
-
National Cancer Institute (NCI)RecruitingPancreatic Acinar Cell CarcinomaUnited States
-
Fujun ZhangRecruitingSarcoma,Soft Tissue | Brachytherapy | Poly(ADP-ribose) Polymerase InhibitorsChina
-
AstraZenecaCompletedOvarian Neoplasms | BRCA1 Protein | BRCA2 ProteinNetherlands, Belgium, United Kingdom, Poland
-
AstraZenecaCompletedPancreatic NeoplasmsUnited States, United Kingdom
-
Washington University School of MedicineActive, not recruiting
-
Affiliated Hospital of Jiangnan UniversityRecruitingCarcinoma, Non-Small-Cell Lung | EGF-R Positive Non-Small Cell Lung CancerChina
-
AstraZenecaCompletedOvarian NeoplasmsSpain, United States, Belgium, United Kingdom, Israel, Poland, Germany, Sweden, Australia
-
AbbVie (prior sponsor, Abbott)CompletedGastric CancerUnited States, Korea, Republic of
-
Eisai Inc.Completed
-
Xiaoxiang ChenNot yet recruitingOvarian Cancer | HRD | PARP InhibitorChina
-
Seoul National University HospitalSamsung Medical Center; Takeda; Asan Medical Center; Yonsei UniversityNot yet recruitingOvarian Cancer | Epithelial Ovarian Cancer | Ovarian Cancer Stage IV | Ovarian Cancer Stage III
-
University of Michigan Rogel Cancer CenterPfizer; Acrotech Biopharma Inc.RecruitingMetastatic Breast Cancer | Metastatic Castration-resistant Prostate Cancer | Metastatic Ovarian CarcinomaUnited States
-
Leiden University Medical CenterRadboud University Medical Center; AstraZeneca; University Medical Center Groningen and other collaboratorsActive, not recruitingUterine Neoplasms | Endometrial Neoplasms | Endometrium CancerNetherlands
-
AbbVie (prior sponsor, Abbott)CompletedBrain Diseases | Central Nervous System Diseases | Neoplasm Metastasis | Brain Neoplasms | Nervous System NeoplasmsUnited States, Canada, Puerto Rico
-
Erasmus Medical CenterRecruitingNeuroendocrine Tumors | Peptide Receptor Radionuclide TherapyNetherlands
-
Sarah E TaylorAmerican Society of Clinical OncologyTerminatedOvarian CancerUnited States
-
Sun Yat-sen UniversityHutchmedRecruitingOvarian Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal Cancer | Ovarian Carcinoma | Fallopian Tube CarcinosarcomaChina
-
SanofiCompleted
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompletedOvarian NeoplasmUnited States, Spain, Australia, Germany, Sweden
-
University of Texas Southwestern Medical CenterWithdrawn
-
Hoosier Cancer Research NetworkClovis Oncology, Inc.CompletedBreast CancerUnited States
-
National Cancer Institute (NCI)CompletedAstrocytoma | Ependymoma | Medulloblastoma | Pontine Glioma | PNETUnited States
-
AbbVie (prior sponsor, Abbott)Completed
-
Tesaro, Inc.RecruitingOvarian NeoplasmsSpain, United States, Canada
-
AbbVieCompletedSmall Cell Lung CancerUnited States, Australia, Belgium, Canada, Czechia, France, Hungary, Korea, Republic of, Netherlands, Romania, Russian Federation, Spain
-
Tesaro, Inc.Completed
-
Xiaoxiang ChenRecruitingOvarian Cancer | PARP Inhibitor | Clinical MarkerChina
-
Paul Mathew, MDHoosier Cancer Research Network; Tesaro, Inc.TerminatedMetastatic Prostate CancerUnited States
-
University Medical Center GroningenAbbVie; Dutch Cancer SocietyWithdrawn
-
University of OklahomaGlaxoSmithKlineTerminatedRecurrent Glioblastoma | Recurrent Glioma | Recurrent Astrocytoma | Recurrent OligodendrogliomaUnited States
-
Centre Francois BaclesseNational Cancer Institute, FranceRecruitingRadiotherapy | PARP Inhibitor | Malignant GliomasFrance
-
Zai Lab (Shanghai) Co., Ltd.Completed
-
Vejle HospitalAbbottCompletedRecurrent, Epithelial Ovarian CancerDenmark